Galapagos NV
GLPG
#4557
Rank
$2.25 B
Marketcap
$33.77
Share price
-1.20%
Change (1 day)
26.29%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): -$0.34

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -$0.34. In 2024 the company made an earnings per share (EPS) of $1.17 a decrease over its 2023 EPS that were of $3.55.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-$0.34-129.1%
2024$1.17-67.16%
2023$3.55-199.64%
2022-$3.5699.03%
2021-$1.79-68.98%
2020-$5.77-298.06%
2019$2.91-554.64%
2018-$0.64-77.18%
2017-$2.81-326.21%
2016$1.24-134.19%
2015-$3.63-371.34%
2014$1.34-445.98%
2013-$0.3932.88%
2012-$0.29-82.07%
2011-$1.62-817.9%
2010$0.2312.73%
2009$0.20-120.79%
2008-$0.96-37.67%
2007-$1.5539.64%
2006-$1.1128.17%
2005-$0.866.25%
2004-$0.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
$11.14-3,384.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$3.75-1,205.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$2.39-805.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$2.07-708.98%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
$7.31-2,254.65%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$5.35-1,677.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
$3.77-1,211.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-$0.61 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$1.24-465.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel